Also publishes as (I. Cernak)
|Up a level|
Donkin, James J., Nimmo, Alan J., Cernak, Ibolja, Blumbergs, Peter C., and Vink, Robert (2009) Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. Journal of Cerebral Blood Flow & Metabolism, 29 (8). pp. 1388-1398.
Nimmo, A.J., Cernak, I., Heath, D.L., Hu, X., Bennett, C.J., and Vink, R. (2004) Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides, 38 (1). pp. 40-47.
Vink, Robert, Donkin, J.J., Cruz, M.I., Nimmo, Alan J., and Cernak, Ibolja (2004) A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats. Journal of the American College of Nutrition, 23 (5). 538S-540S.
O'Connor, Christine, Heath, Deanne L., Cernak, Ibolja, Nimmo, Alan J., and Vink, Robert (2003) Effects of daily versus weekly testing and pre-training on the assessment of neurologic impairment following diffuse traumatic brain injury in rats. Journal of Neurotrauma, 20 (10). pp. 985-993.
Vink, R., Young, A., Bennett, C.J., Hu, X., Connor, C.O., Cernak, I., and Nimmo, A.J. (2003) Neuropeptide release influences brain edema formation after diffuse traumatic brain injury. Acta Neurochirurgica Supplementum, 86. pp. 257-260.
Cernak, Ibolja, Chapman, Sarah M., Hamlin, Gary P., and Vink, Robert (2002) Temporal characterisation of pro- and anti-apoptotic mechanisms following diffuse traumatic brain injury in rats. Journal of Clinical Neuroscience, 9 (5). pp. 565-572.
Vink, Robert, Nimmo, Alan J., and Cernak, Ibolja (2001) An overview of new and novel pharmacotherapies for use in traumatic brain injury. Clinical and Experimental Pharmacology and Physiology, 28 (11). pp. 919-921.